Immunological Targets in Inflammation from the Small Molecule Perspective

Author(s): Angelica M. Bello, Meena K. Purohit, Tracy Jun Yang Cui, Slater Brandon Stead, Lakshmi P. Kotra.

Journal Name: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents)

Volume 10 , Issue 2 , 2011

Become EABM
Become Reviewer


Inflammation and autoimmune disorders have received much greater attention in the recent years due to the elucidation of various molecular mechanisms and the discoveries of various cytokines and other proteins involved in these processes. These discoveries are helping develop novel therapeutics including small molecules and protein therapeutics (biologics) for the treatment of sterile and nonsterile inflammatory disorders. Small molecule drugs have several advantages over protein therapeutics including their affordability for chronic treatments. In this review article, recent successes targeting various inflammatory cytokines and the corresponding receptors such as TLRs, interleukins, p38α as well as recent strategies for developing small molecule antagonists using rational models are discussed.

Keywords: Inflammation, Cytokines, Small molecule targets, Toll-like receptors, p38α kinase, Interferon, autoimmune disorders, pathogens, macrophages, fibrosis

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [121 - 131]
Pages: 11
DOI: 10.2174/1871523011107020121
Price: $65

Article Metrics

PDF: 13